631Accesses
Abstract
Alzheimer’s disease, the most common neurodegenerative disorder of senile dementia, is characterized by two major morpho-pathological hallmarks. Deposition of extracellular neuritic, β-amyloid peptide-containing plaques (senile plaques) in cerebral cortical regions of Alzheimer patients is accompanied by the presence of intracellular neurofibrillary tangles in cerebral pyramidal neurons. Basal forebrain cholinergic dysfunction is also a consistent feature of Alzheimer’s disease, which has been suggested to cause, at least partly, the cognitive deficits observed in patients with Alzheimer’s disease. Impaired cortical cholinergic neurotransmission may also contribute to β-amyloid plaque pathology in Alzheimer’s disease by affecting expression and processing of the β-amyloid precursor protein (APP). Vice versa, low level of soluble β-amyloid has been observed to inhibit cholinergic synaptic function. Deposition of β-amyloid plaques in Alzheimer’s disease is also accompanied by a significant plaque-associated glial up-regulation of interleukin-1, which has been attributed to affect expression and metabolism of APP and to interfere with cholinergic transmission. Understanding the molecular mechanisms underlying the interrelationship between cortical cholinergic dysfunction, β-amyloid formation and deposition, as well as local inflammatory upregulation, would allow to derive potential treatment strategies to pharmacologically intervene in the disease-causing signaling cascade.
This is a preview of subscription content,log in via an institution to check access.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price includes VAT (Japan)
Instant access to the full article PDF.
Similar content being viewed by others
References
A. Nordberg (1992)ArticleTitleNeuroreceptor changes in Alzheimer diseaseCerebrovasc. Brain Met. Rev.4 303–328
L. M. Bierer V. Haroutunian S. Gabriel P. J. Knott L. S. Carlin D. P. Purohit D. P. Perl J. Schmeidler P. Kanof K. L. Davis (1995)ArticleTitleNeurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficitsJ. Neurochem.64 749–760OccurrenceHandle7830069
M. Mesulam (2004)ArticleTitleThe cholinergic lesion of Alzheimer’s disease: pivotal factor or side showLearn Mem.11 43–49OccurrenceHandle10.1101/lm.69204OccurrenceHandle14747516
D. J. Selkoe (2003)ArticleTitleAging, amyloid, and Alzheimer’s disease: a perspective in honor of Carl CotmanNeurochem. Res.28 1705–1713OccurrenceHandle10.1023/A:1026065122854OccurrenceHandle14584824
M. M. Mesulam (1986)ArticleTitleAlzheimer plaques and cortical cholinergic innervationNeuroscience17 275–276OccurrenceHandle10.1016/0306-4522(86)90242-3OccurrenceHandle3960313
M. A. Moran E. J. Mufson P. Gomez-Ramos (1993)ArticleTitleColocalization of cholinesterases with β-amyloid protein in aged and Alzheimer’s brainActa Neuropathol.85 362–369OccurrenceHandle10.1007/BF00334445OccurrenceHandle8480510
D. K. Lahiri M. R. Farlow J. J., NurnbergerSuffixJr N. H. Greig (1997)ArticleTitleEffects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell culturesAnn. NY Acad. Sci.826 416–421OccurrenceHandle9329715
F. Mori C. C. Lai F. Fusi E. Giacobini (1995)ArticleTitleCholinesterase inhibitors increase secretion of APPs in rat brain cortexNeuroreport6 633–636OccurrenceHandle7605915
M. Racchi M. Sironi A. Caprera G. Konig S. Govoni (2001)ArticleTitleShort- and long-term effect of acetylcholinesterase inhibition on the expression and metabolism of the amyloid precursor proteinMol. Psych.6 520–528OccurrenceHandle10.1038/sj.mp.4000878
N. C. Inestrosa A. Alvarez C. A. Perez R. D. Moreno M. Vicente C. Linker O. I. Casanueva J. Soto-Garrido (1996)ArticleTitleAcetylcholinesterase accelerates assembly of amyloid-β peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzymeNeuron16 881–891OccurrenceHandle10.1016/S0896-6273(00)80108-7OccurrenceHandle8608006
X. Zhang (2004)ArticleTitleCholinergic activity and amyloid precursor protein processing in aging and Alzheimer’s diseaseCurr. Drug Targets3 137–152OccurrenceHandle10.2174/1568007043482499OccurrenceHandle15078189
M. Racchi S. Govoni (2003)ArticleTitleThe pharmacology of amyloid precursor protein processingExp. Gerontol.38 145–157OccurrenceHandle10.1016/S0531-5565(02)00158-4OccurrenceHandle12543272
A. Alvarez C. Opazo R. Alarcon J. Garrido N. C. Inestrosa (1997)ArticleTitleAcetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrilsJ. Mol. Biol.272 348–361OccurrenceHandle10.1006/jmbi.1997.1245OccurrenceHandle9325095
M. Bartolini C. Bertucci V. Cavrini V. Andrisano (2003)ArticleTitleβ-Amyloid aggregation induced by human acetylcholinesterase: inhibition studiesBiochem Pharmacol.65 407–416OccurrenceHandle10.1016/S0006-2952(02)01514-9OccurrenceHandle12527333
A. Alvarez R. Alarcon C. Opazo E. O. Campos F. J. Munoz F. H. Calderon F. Dajas M. K. Gentry B. P. Doctor F. G. MelloParticleDe N. C. Inestrosa (1998)ArticleTitleStable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer’s fibrilsJ. Neurosci.18 3213–3223OccurrenceHandle9547230
A. E. Reyes M. A. Chacon M. C. Dinamarca W. Cerpa C. Morgan N. C. Inestrosa (2004)ArticleTitleAcetylcholinesterase-Aβ complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell lossAm. J. Pathol.164 2163–2174OccurrenceHandle15161650
C. Geula M. Mesulam (1989)ArticleTitleSpecial properties of cholinesterases in the cerebral cortex of Alzheimer’s diseaseBrain Res.498 185–189OccurrenceHandle10.1016/0006-8993(89)90419-8OccurrenceHandle2790472
C. R. Schatz C. Geula M. Mesulam (1990)ArticleTitleCompetitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer’s diseaseNeurosci. Lett.117 56–61OccurrenceHandle10.1016/0304-3940(90)90119-TOccurrenceHandle2290622
T. Rees P. I. Hammond H. Soreq S. Younkin S. Brimijoin (2003)ArticleTitleAcetylcholinesterase promotes beta-amyloid plaques in cerebral cortexNeurobiol. Aging24 777–787
N. C. Inestrosa R. Alarcon (1998)ArticleTitleMolecular interactions of acetylcholinesterase with senile plaquesJ. Physiol. (Paris)92 341–344OccurrenceHandle10.1016/S0928-4257(99)80002-3
A. E. Reyes D. R. Perez A. Alvarez J. Garrido M. K. Gentry B. P. Doctor N. C. Inestrosa (1997)ArticleTitleA monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzymeBiochem. Biophys. Res. Commun.232 652–655OccurrenceHandle10.1006/bbrc.1997.6357OccurrenceHandle9126330
R. A. Fuentealba G. Farias J. Scheu M. Bronfman M. P. Marzolo N. C. Inestrosa (2004)ArticleTitleSignal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer diseaseBrain Res. Rev.47 275–289OccurrenceHandle10.1016/j.brainresrev.2004.07.018OccurrenceHandle15572177
G. Sberna J. Saez-Valero K. Beyreuther C. L. Masters D. H. Small (1997)ArticleTitleThe amyloid beta-protein of Alzheimer’s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cellsJ. Neurochem.69 1177–1184OccurrenceHandle9282941
J. Saez-Valero L. R. Fodero A. R. White C. J. Barrow D. H. Small (2003)ArticleTitleAcetylcholinesterase is increased in mouse neuronal and astrocyte cultures after treatment with beta-amyloid peptidesBrain Res.965 283–286OccurrenceHandle10.1016/S0006-8993(02)04159-8OccurrenceHandle12591148
L. R. Fodero S. S. Mok D. Losic L. L. Martin M. I. Aguilar C. J. Barrow B. G. Livett D. H. Small (2004)ArticleTitleα7-nicotinic acetylcholine receptors mediate an Aβ(1–42)-induced increase in the level of acetylcholinesterase in primary cortical neuronesJ. Neurochem.88 1186–1193OccurrenceHandle10.1046/j.1471-4159.2003.02296.xOccurrenceHandle15009674
R. M. Nitsch B. E. Slack R. J. Wurtman J. H. Growdon (1992)ArticleTitleRelease of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptorsScience258 304–307OccurrenceHandle1411529
R. M. Nitsch S.A. Farber J.H. Growdon R.J. Wurtman (1993)ArticleTitleRelease of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slicesProc. Natl. Acad. Sci. USA.90 5191–5193OccurrenceHandle8506366
H. A. Ensinger H. N. Doods A. R. Immel-Sehr F. J. Kuhn G. Lambrecht K. D. Mendla R. E. Muller E. Mutschler A. Sagrada G. Waltheret al. (1993)ArticleTitleWAL 2014 – a muscarinic agonist with preferential neuron-stimulating propertiesLife Sci.52 473–480OccurrenceHandle10.1016/0024-3205(93)90304-LOccurrenceHandle8441328
S. A. Farber R. M. Nitsch J. G. Schulz R. J. Wurtman (1995)ArticleTitleRegulated secretion of β-amyloid precursor protein in rat brainJ. Neurosci.15 7442–7451OccurrenceHandle7472496
A. Walland S. Burkard R. Hammer W. Troger (1997)ArticleTitleIn vivo consequences of M1-receptor activation by talsaclidineLife Sci.60 977–984OccurrenceHandle10.1016/S0024-3205(97)00037-4OccurrenceHandle9121364
D. M. Müller K. Mendla S. A. Farber R. M. Nitsch (1997)ArticleTitleMuscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomainLife Sci.60 985–991OccurrenceHandle10.1016/S0024-3205(97)00038-6OccurrenceHandle9121365
C. Hock A. Maddalena A. Raschig F. Muller-Spahn G. Eschweiler K. Hager I. Heuser H. Hampel T. Muller-Thomsen W. Oertel M. Wienrich A. Signorell C. Gonzalez-Agosti R. M. Nitsch (2003)ArticleTitleTreatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42 in patients with Alzheimer’s diseaseAmyloid10 1–6OccurrenceHandle12762134
R. M. Nitsch M. Deng M. Tennis D. Schoenfeld J. H. Growdon (2002)ArticleTitleThe selective muscarinic agonist AF102B decreases levels of total Ab in CSF of patients with Alzheimer’s diseaseAnn. Neurol.48 913–918OccurrenceHandle10.1002/1531-8249(200012)48:6<913::AID-ANA12>3.0.CO;2-S
A. Y. Hung C. Haass R. M. Nitsch W. Q. Qiu M. Citron R. J. Wurtman J. H. Growdon D. J. Selkoe (1993)ArticleTitleActivation of protein kinase C inhibits cellular production of the amyloid beta-proteinJ. Biol. Chem.268 22959–22962OccurrenceHandle8226807
B. E. Slack J Breu M. A. Petryniak K. Srivastava R. J. Wurtman (1995)ArticleTitleTyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptorJ. Biol. Chem.270 8337–8344OccurrenceHandle10.1074/jbc.270.14.8337OccurrenceHandle7713942
R. Haring A. Fisher D. Marciano Z. Pittel Y. Kloog A. Zuckerman N. Eshhar E. Heldman (1998)ArticleTitleMitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretionJ. Neurochem.71 2094–2103OccurrenceHandle9798935
B. E. Slack (2000)ArticleTitleThe m3 muscarinic acetylcholine receptor is coupled to mitogen-activated protein kinase via protein kinase C and epidermal growth factor receptor kinaseBiochem. J.348IssueIDPt 2 381–387OccurrenceHandle10.1042/0264-6021:3480381OccurrenceHandle10816433
S. Roßner U. Ueberham R. Schliebs J. R. Perez-Polo V. Bigl (1998)ArticleTitleThe regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signalingProg. Neurobiol.56 541–569OccurrenceHandle10.1016/S0301-0082(98)00044-6OccurrenceHandle9775403
L. Lin B. Georgievska A. Mattsson O. Isacson (1999)ArticleTitleCognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activationProc. Natl. Acad. Sci. USA96 12108–12113OccurrenceHandle10.1073/pnas.96.21.12108OccurrenceHandle10518584
H. Seo A. W. Ferree O. Isacson (2002)ArticleTitleCortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal miceEur. J. Neurosci.15 498–505OccurrenceHandle10.1046/j.0953-816x.2001.01884.xOccurrenceHandle11876777
R. M. Canet-Aviles M. Anderton N. M. Hooper A. J. Turner P. F. Vaughan (2002)ArticleTitleMuscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(alpha), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase CMol. Brain Res.102 62–72OccurrenceHandle10.1016/S0169-328X(02)00184-5OccurrenceHandle12191495
T. Zuechner J. R. Perez-Polo R. Schliebs (2004)ArticleTitleβ-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signalingJ. Neurosci. Res.77 250–257OccurrenceHandle10.1002/jnr.20152OccurrenceHandle15211591
S. Efthimiopoulos D. Vassilacopoulou J. A. Ripellino N. Tezapsidis N. K. Robakis (1996)ArticleTitleCholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cellsProc. Natl. Acad. Sci. USA93 8046–8050OccurrenceHandle10.1073/pnas.93.15.8046OccurrenceHandle8755600
J. Seo S. Kim H. Kim C. H. Park S. Jeong J. Lee S. H. Choi K. Chang J. Rah J. Koo E. Kim Y. Suh (2001)ArticleTitleEffects of nicotine on APP secretion and Aβ- or CT(105)-induced toxicityBiol. Psych.49 240–247OccurrenceHandle10.1016/S0006-3223(00)01124-0
T. Utsuki M. Shoaib H. W. Holloway D. K. Ingram W. C. Wallace V. Haroutunian K. Sambamurti D. K. Lahiri N. H. Greig (2002)ArticleTitleNicotine lowers the secretion of the Alzheimer’s amyloid β-protein precursor that contains amyloid β-peptide in ratJ. Alzheimers Dis.4 405–415OccurrenceHandle12446972
D. K. Lahiri T. Utsuki D. Chen M. R. Farlow M. Shoaib D. K. Ingram N. H. Greig (2002)ArticleTitleNicotine reduces the secretion of Alzheimer’s β-amyloid precursor protein containing β-amyloid peptide in the rat without altering synaptic proteinsAnn. NY Acad. Sci.965 364–372OccurrenceHandle12105112
A. R. Salomon K. J. Marcinowski R. P. Friedland M. G. Zagorski (1996)ArticleTitleNicotine inhibits amyloid formation by the β-peptideBiochemistry.35 13568–13578OccurrenceHandle10.1021/bi9617264OccurrenceHandle8885836
K. Ono K. Hasegawa M. Yamada H. Naiki (2002)ArticleTitleNicotine breaks down preformed Alzheimer’s β-amyloid fibrilsin vitroBiol. Psychiatry.52 880–886OccurrenceHandle10.1016/S0006-3223(02)01417-8OccurrenceHandle12399141
A. Nordberg E. Hellström-Lindahl M. Lee M. Johnson M Mousavi R. . Hall E. Perry I. Bednar J. Court (2002)ArticleTitleChronic nicotine treatment reduces b-amyloidosis in the brain of mouse model of Alzheimer’s disease (APPsw)J. Neurochem.81 655–658OccurrenceHandle10.1046/j.1471-4159.2002.00874.xOccurrenceHandle12065674
E. Hellstrom-Lindahl J. Court J. Keverne M. Svedberg M. Lee A. Marutle A. Thomas E. Perry I. Bednar A. Nordberg (2004)ArticleTitleNicotine reduces Aβ in the brain and cerebral vessels of APPsw miceEur. J. Neurosci.19 2703–2710OccurrenceHandle10.1111/j.0953-816X.2004.03377.xOccurrenceHandle15147304
E. J. Mufson E. Y. Chen E. J. Cochran L. A. Beckett D. A. Bennett J. H. Kordower (1999)ArticleTitleEntorhinal cortex β-amyloid load in individuals with mild cognitive impairmentExp. Neurol.158 469–490OccurrenceHandle10.1006/exnr.1999.7086OccurrenceHandle10415154
T. Harkany S. O’Mahony J. P. Kelly K. Soos I. Toro B. Penke P. G. Luiten C. Nyakas K. Gulya B. E. Leonhard (1998)ArticleTitleβ-amyloid (Phe(SO3H)24)25–35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervationBehav. Brain Res.90 133–145OccurrenceHandle10.1016/S0166-4328(97)00091-0OccurrenceHandle9580273
S. O’Mahony T. Harkany A. A. M. Rensink I. Abraham G. I. DeJong J. L. Varga M. Zarandi B. Penke C. Nyakas P. G. M. Luiten B. E. Leonhard (1998)ArticleTitleβ-Amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: reversal by NMDA receptor blockadeBrain Res. Bull.45 405–411OccurrenceHandle10.1016/S0361-9230(97)00405-XOccurrenceHandle9527015
T. Harkany J. Mulder M. Sasvari I. Abraham C. Konya M. Zarandi B. Penke P. G. Luiten C. Nyakas (1999)ArticleTitleN-methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neuron against β-amyloid neurotoxicityNeurobiol. Dis.6 109–221OccurrenceHandle10.1006/nbdi.1998.0230OccurrenceHandle10343326
T. Harkany I. Abraham W. Timmermann G. Laskay B. Toth M. Sasvari C. Konya J. B. Sebens J. Korf C. Nyakas M. Zarandi K. Soos B. Penk P. G. Luiten (2000)ArticleTitleβ-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalisEur. J. Neurosci.12 2735–2745OccurrenceHandle10.1046/j.1460-9568.2000.00164.xOccurrenceHandle10971616
T. Harkany I. Abraham C. Konya C. Nyakas M. Zarandim B. Penke P. G. Luiten (2000)ArticleTitleMechanisms of β-amyloid neurotoxicity: perspectives of pharmacotherapyRev. Neurosci.11 329–382OccurrenceHandle11065280
W. T. Kimberly M. J. LaVoie B. L. Ostaszewski W. Ye M. S. Wolfe D. J. Selkoe (2003)ArticleTitleγ-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2Proc. Natl. Acad. Sci. USA100 6382–6387OccurrenceHandle10.1073/pnas.1037392100OccurrenceHandle12740439
J. T. Gau M. L. Steinhilb T. C. Kao C. J. D’Amato J. R. Gaut K. A. Frey R. S. Turner (2002)ArticleTitleStable β-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 miceAm. J. Pathol.160 731–738OccurrenceHandle11839594
D. Hernandez K. Sugaya T. Qu E. McGowan K. Duff M. McKinney (2001)ArticleTitleSurvival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genesNeuroreport12 1377–1384OccurrenceHandle10.1097/00001756-200105250-00018OccurrenceHandle11388415
L. Hu T. P. Wong S. L. Cote K. F. Bell A. C. Cuello (2003)ArticleTitleThe impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer’s disease-like transgenic miceNeuroscience121 421–432OccurrenceHandle10.1016/S0306-4522(03)00394-4OccurrenceHandle14522000
D. C. German U. Yazdani S. G. Speciale P. Pasbakhsh D. Games C. L. Liang (2003)ArticleTitleCholinergic neuropathology in a mouse model of Alzheimer’s diseaseJ. Comp. Neurol.462 371–381OccurrenceHandle10.1002/cne.10737OccurrenceHandle12811807
F. C. Bronfman D. Moechars F. LeuvenParticleVan (2000)ArticleTitleAcetylcholine-positive fibre deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein London mutant transgenic miceNeurobiol. Dis.7 152–168OccurrenceHandle10.1006/nbdi.2000.0283OccurrenceHandle10860782
S. Boncristiano M. E. Calhoun P. H. Kelly M. Pfeifer L. Bondolfi M. Stalder A. L. Phinney D. Abramowski C. Sturchler-Pierrat A. Enz B. Sommer M. Staufenbiel M. Jucker (2002)ArticleTitleCholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosisJ. Neurosci.22 3234–3243OccurrenceHandle11943824
S. Jaffar S. E. Counts S. Y. Ma E. Dadko M. N. Gordon D. Morgan E. J. Mufson. (2001)ArticleTitleNeuropathology of mice carrying mutant APPSWE and/or PS1M146L transgenes: Alterations in the p75NTR cholinergic basal forebrain septohippocampal pathwayExp. Neurol.170 227–243OccurrenceHandle10.1006/exnr.2001.7710OccurrenceHandle11476589
T. P. Wong T. Debeir K. Duff A. C. Cuello (1999)ArticleTitleReorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenesJ. Neurosci.19 2706–2716OccurrenceHandle10087083
J. Hartmann C. Erb U. Ebert K. H. Baumann A. Popp G. König J. Klein (2004)ArticleTitleCentral cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic miceNeuroscience125 1009–1017OccurrenceHandle10.1016/j.neuroscience.2004.02.038OccurrenceHandle15120860
J. Apelt A. Kumar R. Schliebs (2002)ArticleTitleImpairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor proteinBrain Res.953 17–30OccurrenceHandle10.1016/S0006-8993(02)03262-6OccurrenceHandle12384234
H. J. Lüth J. Apelt A. Ihunwo R. Schliebs (2003)ArticleTitleDegeneration of β-amyloid-associated cholinergic structures in transgenic APPSW miceBrain Res.977IssueID2003 16–22OccurrenceHandle10.1016/S0006-8993(03)02658-1OccurrenceHandle12788508
M. Klingner J. Apelt A. Kumar D. Sorger O. Sabri J. Steinbach M. Scheunemann R. Schliebs (2003)ArticleTitleAlterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with β-amyloid plaque pathologyInt. J. Devl. Neurosci.21 357–369OccurrenceHandle10.1016/j.ijdevneu.2003.08.001
C. Haass D. J. Selkoe (1993)ArticleTitleCellular processing of β-amyloid precursor protein and the genesis of amyloid beta-peptideCell75 1039–1042OccurrenceHandle10.1016/0092-8674(93)90312-EOccurrenceHandle8261505
M. Shoji T. E. Golde J. Ghiso T. T. Cheung S. Estus L. M. Shaffer X. D. Cai D. M. McKay R. Tintner B. Frangione (1992)ArticleTitleProduction of the Alzheimer amyloid beta protein by normal proteolytic processingScience258 126–129OccurrenceHandle1439760
D. S. Auld T. J. Kornecook S. Bastianetto R. Quirion (2002)ArticleTitleAlzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategiesProg. Neurobiol.68 209–245OccurrenceHandle10.1016/S0301-0082(02)00079-5OccurrenceHandle12450488
S. Kar S. P. Slowikowski D. Westaway H. T. Mount (2004)ArticleTitleInteractions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s diseaseJ. Psych. Neurosci.29 427–441
W. A. Pedersen M. A. Kloczewiak J. K. Blusztajn (1996)ArticleTitleAmyloid β-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrainProc. Natl. Acad. Sci. USA93 8068–8071OccurrenceHandle10.1073/pnas.93.15.8068OccurrenceHandle8755604
M. Hoshi A. Takashima M. Murayama K. Yasutake N. Yoshida K. Ishiguro T. Hoshino K. Imahori (1997)ArticleTitleNontoxic amyloid β peptide 1–42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer’s diseaseJ. Biol. Chem.272 2038–2041OccurrenceHandle10.1074/jbc.272.4.2038OccurrenceHandle8999897
J. F. Kelly K. Furukawa S. W. Barger M. R. Rengen R. J. Mark E. M. Blanc G. S. Roth M. P. Mattson (1996)ArticleTitleAmyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neuronsProc. Natl. Acad. Sci. USA93 6753–6758OccurrenceHandle10.1073/pnas.93.13.6753OccurrenceHandle8692890
Z. Z. Guan H. Miao J. Y. Tian C. Unger A. Nordberg X. Zhang (2001)ArticleTitleSuppressed expression of nicotinic acetylcholine receptors by nanomolar β-amyloid peptides in PC12 cellsJ. Neural. Transm.108 1417–1433OccurrenceHandle10.1007/s007020100017OccurrenceHandle11810405
Q. Liu H. Kawai D. K. Berg (2001)ArticleTitleβ-amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neuronsProc. Natl. Acad. Sci. USA98 4734–4739OccurrenceHandle10.1073/pnas.081553598OccurrenceHandle11274373
T. Teaktong A. J. Graham J. A. Court R. H. Perry E. Jaros M. Johnson R. Hall E. K. Perry (2004)ArticleTitleNicotinic acetylcholine receptor immunohistochemistry in Alzheimer’s disease and dementia with Lewy bodies; differential and astroglial pathologyJ. Neurol. Sci.225 39–49OccurrenceHandle10.1016/j.jns.2004.06.015OccurrenceHandle15465084
H. Y. Wang D. H. Lee M. R. D’Andrea P. A. Peterson R. P. Shank A. B. Reitz (2000)ArticleTitleβ-Amyloid(1–42) binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer’s disease pathologyJ. Biol. Chem.275 5626–5632OccurrenceHandle10.1074/jbc.275.8.5626OccurrenceHandle10681545
H. Y. Wang D. H. Lee C. B. Davis R. P. Shank (2000)ArticleTitleAmyloid peptide Aβ (1–42) binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptorsJ. Neurochem.75 1155–1161OccurrenceHandle10.1046/j.1471-4159.2000.0751155.xOccurrenceHandle10936198
Z. Z. Guan W. F. Yu K. R. Shan T. Nordman J. Olsson A. Nordberg (2003)ArticleTitleLoss of nicotinic receptors induced by β-amyloid peptides in PC12 cells: possible mechanism involving lipid peroxidationJ. Neurosci. Res.71 397–406OccurrenceHandle10.1002/jnr.10496OccurrenceHandle12526028
K. T. Dineley M. Westerman D. Bui K. Bell K. H. Ashe J. D. Sweatt (2001)ArticleTitleβ-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors:In vitro andin vivo mechanisms related to Alzheimer’s diseaseJ. Neurosci.21 4125–4133OccurrenceHandle11404397
K. T. Dineley K. A. Bell D. Bui J. D. Sweatt (2002)ArticleTitleβ-Amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytesJ. Biol. Chem.277 25056–250561OccurrenceHandle10.1074/jbc.M200066200OccurrenceHandle11983690
D. L. Pettit Z. Shao J. L. Yakel (2001)ArticleTitleβ-amyloid (1–42) peptide directly modulates nicotinic receptors in the rat hippocampal sliceJ. Neurosci.21 RC120OccurrenceHandle11150356
H. Tozaki A. Matsumoto T. Kanno K. Nagai T. Nagata I. Yamamoto T. Nishizaki (2002)ArticleTitleThe inhibitory and facilitatory actions of amyloid-β peptides on nicotinic Ach receptors and AMPA receptorsBiochem. Biophys. Res. Commun.294 42–45OccurrenceHandle10.1016/S0006-291X(02)00429-1OccurrenceHandle12054737
F. Grassi E. Palma R. Tonini M. Amici M. Ballivet F. Eusebi (2003)ArticleTitleAmyloid β (1–42) peptide alters the gating of human and mouse α-bungarotoxin-sensitive nicotinic receptorsJ. Physiol.547IssueIDPt 1 147–57OccurrenceHandle10.1113/jphysiol.2002.035436OccurrenceHandle12562926
D. H. Lee H. Y. Wang (2003)ArticleTitleDifferential physiologic responses of α7 nicotinic acetylcholine receptors to β-amyloid1–40 and β-amyloid1–42J. Neurobiol.55 25–30OccurrenceHandle10.1002/neu.10203OccurrenceHandle12605456
J. K. Blusztajn B. Berse (2000)ArticleTitleThe cholinergic neuronal phenotype in Alzheimer’s diseaseMetab. Brain Dis.15 45–64OccurrenceHandle10.1023/A:1011161718572OccurrenceHandle10885540
T. G. Beach Y. M. Kuo K. Spiegel M. R. Emmerling L. I. Sue K. Kokjohn A. E. Roher (2000)ArticleTitleThe cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer diseaseJ. Neuropathol. Exp. Neurol.59 308–313OccurrenceHandle10759186
M. Cacquevel N. Lebeurrier S. Cheenne D. Vivien (2004)ArticleTitleCytokines in neuroinflammation and Alzheimer’s diseaseCurr. Drug Targets.5 529–534OccurrenceHandle10.2174/1389450043345308OccurrenceHandle15270199
P. Eikelenboom W. A. GoolParticlevan (2004)ArticleTitleNeuroinflammatory perspectives on the two faces of Alzheimer’s diseaseJ.␣Neural Transm.111 281–294OccurrenceHandle10.1007/s00702-003-0055-1OccurrenceHandle14991455
J. Apelt R. Schliebs (2001)ArticleTitleβ-Amyloid-induced glial expression of both pro-and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathologyBrain Res.894 21–30OccurrenceHandle10.1016/S0006-8993(00)03176-0OccurrenceHandle11245811
W. C. Benzing J. R. Wujek E. K. Ward D. Shaffer K. H. Ashe S. G. Younkin K. R. Brunden (1999)ArticleTitleEvidence for glial-mediated inflammation in aged APP(SW) transgenic miceNeurobiol. Aging20 581–589OccurrenceHandle10.1016/S0197-4580(99)00065-2OccurrenceHandle10674423
M. N. Gordon L. A. Holcomb P. T. Jantzen G. DiCarlo D. Wilcock K. W. Boyett K. Connor J. Melachrino J. P. O’Callaghan D. Morgan (2002)ArticleTitleTime course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouseExp. Neurol.173 183–195OccurrenceHandle10.1006/exnr.2001.7754OccurrenceHandle11822882
G. L. Wenk L. B. Willard (1998)ArticleTitleThe neuronal mechanisms underlying cholinergic cell death within the basal forebrainInt. J. Dev. Neurosci.16 729–735OccurrenceHandle10.1016/S0736-5748(98)00081-1OccurrenceHandle10198820
L. B. Willard B. Hauss-Wegrzyniak G. L. Wenk (1999)ArticleTitlePathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of ratsNeuroscience88 193–200OccurrenceHandle10.1016/S0306-4522(98)00216-4OccurrenceHandle10051200
G. L. Wenk K. McGann A. Mencarelli B. Hauss-Wegrzyniak P. DelSoldato S. Fiorucci (2000)ArticleTitleMechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neuronsEur. J. Pharmacol.402 77–85OccurrenceHandle10.1016/S0014-2999(00)00523-9OccurrenceHandle10940360
M. McMillian L. Y. Kong S. M. Sawin B. Wilson K. Das P. Hudson J. S. Hong G. Bing (1995)ArticleTitleSelective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial culturesBiochem. Biophys. Res. Commun.215 572–577OccurrenceHandle10.1006/bbrc.1995.2503OccurrenceHandle7487994
L. B. Willard B. Hauss-Wegrzyniak W. Danysz G. L. Wenk (2000)ArticleTitleThe cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibitionExp. Brain Res.134 58–65OccurrenceHandle10.1007/s002210000446OccurrenceHandle11026726
G. L. Wenk K. McGann B. Hauss-Wegrzyniak S. Rosi (2003)ArticleTitleThe toxicity of tumor necrosis factor-alpha upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for Alzheimer’s diseaseNeuroscience121 719–729OccurrenceHandle10.1016/S0306-4522(03)00545-1OccurrenceHandle14568031
G. L. Wenk K. McGann-Gramling B. Hauss-Wegrzyniak (2004)ArticleTitleThe presence of the APP (swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammationNeuroscience125 769–776OccurrenceHandle10.1016/j.neuroscience.2004.01.050OccurrenceHandle15099690
R. D. Shytle T. Mori K. Townsend M. Vendrame N. Sun J. Zeng J. Ehrhart A. A. Silver P. R. Sanberg J. Tan (2004)ArticleTitleCholinergic modulation of microglial activation by α7 nicotinic receptorsJ. Neurochem.89 337–343OccurrenceHandle15056277
B. Brugg Y. L. Dubreuil G. Huber E. E. Wollman N. Delhaye-Bouchaud J. Mariani (1995)ArticleTitleInflammatory processes induces β-amyloid precursor protein changes in mouse brainProc. Natl. Acad. Sci. USA92 3032–3035OccurrenceHandle7708769
J. D. Buxbaum M. Oishi H. I. Chen R. Pinkas-Kramarski E. A. Jaffe S. E. Gandy P. Greengard (1992)ArticleTitleCholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursorProc. Natl. Acad. Sci. USA89 10075–10078OccurrenceHandle1359534
G. Forloni F. Demicheli S. Giorgi C. Bendotti N. Angeretti (1992)ArticleTitleExpression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1Mol. Brain Res.16 128–134OccurrenceHandle10.1016/0169-328X(92)90202-MOccurrenceHandle1334190
D. Goldgaber M. I. Lerman O. W. McBride U. Saffiotti D. C. Gajdusek (1987)ArticleTitleCharacterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s diseaseScience235 877–880OccurrenceHandle3810169
J. T. Rogers L. M. Leiter J. McPhee C. M. Cahill S. S. Zhan H. Potter L. N. Nilsson (1999)ArticleTitleTranslation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5’-untranslated region sequencesJ.␣Biol. Chem.274 6421–6431OccurrenceHandle10.1074/jbc.274.10.6421OccurrenceHandle10037734
J. G. Sheng S. G. Zhu R. A. Jones W. S. Griffin R. E. Mrak (2000)ArticleTitleInterleukin-1 promotes expression and phosphorylation of neurofilament and tau proteinsin vivoExp. Neurol.163 388–391OccurrenceHandle10.1006/exnr.2000.7393OccurrenceHandle10833312
J. G. Sheng W. S. Griffin M. C. Royston R. E. Mrak (1998)ArticleTitleDistribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer’s diseaseNeuropathol. Appl. Neurobiol.24 278–283OccurrenceHandle10.1046/j.1365-2990.1998.00122.xOccurrenceHandle9775393
Y. Li L. Liu J. Kang J. G. Sheng S. W. Barger R. E. Mrak W. S. T. Griffin (2000)ArticleTitleNeuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expressionJ. Neurosci.20 149–155OccurrenceHandle10627591
M. Hartlage-Rübsamen U. Zeitschel J. Apelt U. Gärtner H. Franke T. Stahl A. Günther R. Schliebs M. Penkowa V. Bigl S. Roßner (2003)ArticleTitleAstrocytic expression of the Alzheimer’s disease β-secretase (BACE1) is stimulus-dependentGlia41 169–179OccurrenceHandle10.1002/glia.10178OccurrenceHandle12509807
S. Roßner J. Apelt R. Schliebs J. R. Perez-Polo V. Bigl (2001)ArticleTitleNeuronal and glial β-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathologyJ. Neurosci. Res.64 437–446OccurrenceHandle10.1002/jnr.1095OccurrenceHandle11391698
S. Roßner G. Mehlhorn R. Schliebs V. Bigl (2001)ArticleTitleIncreased neuronal and glial expression of protein kinase C isoforms in neocortex of transgenic Tg2576 mice with amyloid pathologyEur. J. Neurosci.13 269–278OccurrenceHandle10.1046/j.1460-9568.2001.01388.xOccurrenceHandle11168531
T. Wyss-Coray J.D. Loike T. C. Brionne E. Lu R. Anankov F. Yan S. C. Silverstein J. Husemann (2003)ArticleTitleAdult mouse astrocytes degrade amyloid-βin vitro andin situNat. Med.9 453–457OccurrenceHandle10.1038/nm838OccurrenceHandle12612547
J. Apelt K. Ach R. Schliebs (2003)ArticleTitleAging-related down-regulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaquesNeurosci. Lett.339 183–186OccurrenceHandle10.1016/S0304-3940(03)00030-2OccurrenceHandle12633883
R. Hellweg C. A. Gericke K. Jendroska H. D. Hartung J. Cervos-Navarro (1998)ArticleTitleNGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer’s diseaseInt. J. Dev. Neurosci.16 787–794OccurrenceHandle10.1016/S0736-5748(98)00088-4OccurrenceHandle10198825
R. Katoh-Semba R. Semba I. K. Takeuchi K. Kato (1998)ArticleTitleAge-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3Neurosci. Res.31 227–234OccurrenceHandle10.1016/S0168-0102(98)00040-6OccurrenceHandle9809668
K. Murase T. Nabeshima Y. Robitaille R. Quirion M. Ogawa K. Hayashi (1993)ArticleTitleNGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer’s diseaseBiochem. Biophys. Res. Commun.193 198–203OccurrenceHandle10.1006/bbrc.1993.1609OccurrenceHandle8503908
M. Narisawa-Saito K. Wakabayashi S. Tsuji H. Takahashi H. Nawa (1996)ArticleTitleRegional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer’s diseaseNeuroreport7 2925–2928OccurrenceHandle9116211
J. D. Cooper D. Lindholm M. V. Sofroniew (1994)ArticleTitleReduced transport of 125I-NGF by cholinergic neurons and downregulated TrkA expression in the medial septum of aged ratsNeuroscience62 625–629OccurrenceHandle10.1016/0306-4522(94)90462-6OccurrenceHandle7532836
S. DeLacalle J. D. Cooper C. N. Svendsen S. B. Dunnett M. V. Sofroniew (1996)ArticleTitleReduced retrograde labeling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged ratsNeuroscience75 19–27OccurrenceHandle10.1016/0306-4522(96)00239-4OccurrenceHandle8923519
M. V. Sofroniew C. L. Howe W. C. Mobley (2001)ArticleTitleNerve growth factor signaling, neuroprotection, and neural repairAnnu. Rev. Neurosci.24 1217–1281OccurrenceHandle10.1146/annurev.neuro.24.1.1217OccurrenceHandle11520933
S. Capsoni G. Ugolini A. Comparini F. Ruberti N. Berardi A. Cattaneo (2000)ArticleTitleAlzheimer-like neurodegeneration in aged antinerve growth factor transgenic miceProc. Natl. Acad. Sci. USA97 6826–6831OccurrenceHandle10.1073/pnas.97.12.6826OccurrenceHandle10841577
O. Isacson H. Seo L. Lin D. Albeck A. C. Granholm (2002)ArticleTitleAlzheimer’s disease and Down’s syndrome: roles of APP, trophic factors and AchTrends Neurosci.25 79–84OccurrenceHandle10.1016/S0166-2236(02)02037-4OccurrenceHandle11814559
C. Wang R. J. Wurtman R. K. Lee (2000)ArticleTitleAmyloid precursor protein and membrane phospholipids in primary cortical neurons increase with development, or after exposure to nerve growth factor or Aβ(1–40)Brain Res.865 157–167OccurrenceHandle10.1016/S0006-8993(00)02183-1OccurrenceHandle10821917
S. E. Counts J. J. Lah A. I. Levey (2001)ArticleTitleThe regulation of presenilin-1 by nerve growth factorJ. Neurochem.76 679–89OccurrenceHandle10.1046/j.1471-4159.2001.00014.xOccurrenceHandle11158238
W. Araki R. J. Wurtman (1998)ArticleTitleIncreased expression of amyloid precursor protein and amyloid precursor-like protein 2 during trophic factor withdrawal-induced death of neuronal PC12 cellsMol Brain Res.56 169–177OccurrenceHandle10.1016/S0169-328X(98)00050-3OccurrenceHandle9602112
A. Villa M. J. Larasa A. Pascual (2001)ArticleTitleNerve growth factor modulates the expression and secretion of β-amyloid precursor protein through different mechanisms in PC12 cellsJ. Neurochem.77 1077–1084OccurrenceHandle10.1046/j.1471-4159.2001.00315.xOccurrenceHandle11359873
S. Capsoni S. Giannotta A. Cattaneo (2002)ArticleTitleb-amyloid plaques in a model for sporadic Alzheimer’s disease based on transgenic anti-nerve growth factor antibodiesMol. Cell Neurosci.21 15–28OccurrenceHandle10.1006/mcne.2002.1163OccurrenceHandle12359148
R. Haring D. Gurwitz J. Barg R. Pinkas-Kramarski E. Heldman Z. Pittel H. D. Danenberg A. Wengier H. Meshulam D. Marcianoet al. (1995)ArticleTitleNGF promotes amyloid precursor protein secretion via muscarinic receptor activationBiochem. Biophys. Res. Commun.213 15–23OccurrenceHandle10.1006/bbrc.1995.2092OccurrenceHandle7639729
N. B. Chauhan G. J. Siegel (2003)ArticleTitleEffect of PPF and ALCAR on the induction of NGF-and p75-mRNA and on APP processing in Tg2576 brainNeurochem. Int.43 225–233OccurrenceHandle10.1016/S0197-0186(03)00006-8OccurrenceHandle12689602
N. B. Chauhan G. J. Siegel D. L. Feinstein (2005)ArticleTitlePropentofylline attenuates tau hyperphosphorylation in Alzheimer’s Swedish mutant model Tg2576Neuropharmacology48 93–104OccurrenceHandle10.1016/j.neuropharm.2004.09.014OccurrenceHandle15617731
S. Roßner U. Ueberham R. Schliebs J. R. Perez-Polo V. Bigl (1998)ArticleTitleNeurotrophin binding to the p75 neurotrophin receptor is necessary but not sufficient to mediate NGF-effects on APP secretion in PC-12 cellsJ. Neural Transm., [Suppl.]53 279–285
A. Salehi J. D. Delcroix D. F. Swaab (2004)ArticleTitleAlzheimer’s disease and NGF signalingJ. Neural Transm.111 323–345OccurrenceHandle10.1007/s00702-003-0091-xOccurrenceHandle14991458
S. Rabizadeh C. M. Bitler L. L. Butcher D. E. Bredesen (1994)ArticleTitleExpression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicityProc. Natl. Acad. Sci. USA91 10703–1076OccurrenceHandle7938014
M. Yaar S. Zhai R.E. Fine P. B. Eisenhauer B. L. Arble K. B. Stewart B. A. Gilchrest (2002)ArticleTitleAmyloid β binds to trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signalingJ. Biol. Chem.277 7720–7725OccurrenceHandle10.1074/jbc.M110929200OccurrenceHandle11756426
P. Kuner R. Schubenel C. Hertel (1998)ArticleTitleβ-amyloid binds to p57NTR and activates NFκB in human neuroblastoma cellsJ. Neurosci. Res.54 798–804OccurrenceHandle10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.0.CO;2-TOccurrenceHandle9856863
G. Perini V. Della-Bianca V. Politi G. Della-Valle I. Dal-Pra F. Rossi U. Armato (2002)ArticleTitleRole of p75 neurotrophin receptor in the neurotoxicity by β-amyloid peptides and synergistic effect of inflammatory cytokinesJ.␣Exp. Med.195 907–918OccurrenceHandle10.1084/jem.20011797OccurrenceHandle11927634
Y. Zhang Y. Hong Y. Bounhar M. Blacker X. Roucou O. Tounekti E. Vereker W. J. Bowers H. J. Federoff C. G. Goodyer A. LeBlanc (2003)ArticleTitlep75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicityJ. Neurosci.23 7385–7394OccurrenceHandle12917374
A. Salehi M. Ocampo J. Verhaagen D. F. Swaab (2000)ArticleTitleP75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer’s diseaseExp. Neurol.161 245–258OccurrenceHandle10.1006/exnr.1999.7252OccurrenceHandle10683291
E. J. Mufson S. Y. Ma J. Dills E. J. Cochran S. Leurgans J. Wuu D. A. Bennett S. Jaffar M. L. Gilmor A. I. Levey J. H. Kordower (2002)ArticleTitleLoss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer’s diseaseJ. Comp. Neurol.443 136–153OccurrenceHandle10.1002/cne.10122OccurrenceHandle11793352
S. E. Counts M. Nadeem J. Wuu S. D. Ginsberg H. U. Saragovi E. J. Mufson (2004)ArticleTitleReduction of cortical trkA but not p75NTR protein in early-stage Alzheimer’s diseaseAnn. Neurol.56 520–531OccurrenceHandle10.1002/ana.20233OccurrenceHandle15455399
M. Eriksdotter-Jönhagen A. Nordberg K. Amberla L. Backman T. Ebendal B. Meyerson L. Olson M. Seiger-Shigeta E. Theodorsson M. Vittanen B. Winblad L. O. Wahlund (1998)ArticleTitleIntracerebroventricular infusion of nerve growth factor in three patients with Alzheimer’s diseaseDement. Geriatr. Cogn. Disord.9 246–257OccurrenceHandle10.1159/000017069OccurrenceHandle9701676
J. Winkler G. A. Ramirez L. J. Thal J. J. Waite (2000)ArticleTitleNerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviorsJ. Neurosci.20 834–844OccurrenceHandle10632613
M. H. Tuszynski (2000)ArticleTitleIntraparenchymal NGF infusions rescue degenerating cholinergic neuronsCell Transplant.9 629–636OccurrenceHandle11144960
P. Francotte A. Graindorge S. Boverie P. TullioParticlede B. Pirotte (2004)ArticleTitleNew trends in the design of drugs against Alzheimer’s diseaseCurr. Med. Chem.11 1757–1778OccurrenceHandle15279580
J. B. Standridge (2004)ArticleTitlePharmacotherapeutic approaches to the prevention of Alzheimer’s diseaseAm. J. Geriatr. Pharmacother.2 119–132OccurrenceHandle10.1016/S1543-5946(04)90017-7OccurrenceHandle15555488
B. Wolozin (2004)ArticleTitleCholesterol, statins and dementiaCurr. Opin. Lipidol.15 667–672OccurrenceHandle10.1097/00041433-200412000-00007OccurrenceHandle15529026
B. Schmitt T. Bernhardt H. J. Moeller I. Heuser L. Frolich (2004)ArticleTitleCombination therapy in Alzheimer’s disease: a review of current evidenceCNS Drugs18 827–844OccurrenceHandle15521788
E. Giacobini (2004)ArticleTitleCholinesterase inhibitors: new roles and therapeutic alternativesPharmacol. Res.50 433–440OccurrenceHandle10.1016/j.phrs.2003.11.017OccurrenceHandle15304240
K. T. Shaw T. Utsuki J. Rogers Q. S. Yu K. Sambamurti A. Brossi Y. W. Ge D. K. Lahiri N. H. Greig (2001)ArticleTitlePhenserine regulates translation of beta-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug developmentProc. Natl. Acad. Sci. USA98 7605–7610OccurrenceHandle10.1073/pnas.131152998OccurrenceHandle11404470
A. Venti T. Giordano P. Eder A. I. Bush D. K. Lahiri N. H. Greig J. T. Rogers (2004)ArticleTitleThe integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5′-untranslated regionAnn. NY Acad. Sci.1035 34–48OccurrenceHandle10.1196/annals.1332.003OccurrenceHandle15681799
L. J. Morse S. M. Payton G. D. Cuny J. T. Rogers (2004)ArticleTitleFDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor proteinJ. Mol. Neurosci.24 129–136OccurrenceHandle10.1385/JMN:24:1:129OccurrenceHandle15314261
Author information
Authors and Affiliations
Paul Flechsig Institute for Brain Research, Department of Neurochemistry, University of Leipzig, D-04109, Jahnallee 59, Leipzig, Germany
Reinhard Schliebs
- Reinhard Schliebs
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toReinhard Schliebs.
Rights and permissions
About this article
Cite this article
Schliebs, R. Basal Forebrain Cholinergic Dysfunction in Alzheimer’s Disease – Interrelationship with β-amyloid, Inflammation and Neurotrophin Signaling.Neurochem Res30, 895–908 (2005). https://doi.org/10.1007/s11064-005-6962-9
Accepted:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative